Housing, sanitation and living conditions affecting SARS-CoV-2 prevention interventions in 54 African countries. (23rd July 2021)

• Record Type: Journal Article
• Authors: Brewer, Timothy F.; Zhang, Mary; Gordon, David; Chung, Roger Yat-Nork; Dejene, Negussie; Fonta, Cynthia L.; Grieve, Tigist; Halleröd, Björn; Harris, Richard; Lanau, Alba; Leibbrandt, Murray; Mekonen, Yehualashet; Muguni, Bongai; Najera, Hector; Nandy, Shailen; Heymann, S. Jody
• Is Part Of: Epidemiology and infection. Volume 149(2021)
• Publication Date: 2021-07-23
• Subjects: COVID-19 -- non-pharmacologic interventions -- prevention -- Africa -- public health; Communicable diseases -- Periodicals; Epidemiology -- Periodicals; 614.4
• DOI: 10.1017/S0950268821001734
• Languages: English
• ISSNs: 0950-2688

Abstract

Abstract: The feasibility of non-pharmacological public health interventions (NPIs) such as physical distancing or isolation at home to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission in low-resource countries is unknown. Household survey data from 54 African countries were used to investigate the feasibility of SARS-CoV-2 NPIs in low-resource settings. Across the 54 countries, approximately 718 million people lived in households with ⩾6 individuals at home (median percentage of at-risk households 56% (95% confidence interval (CI), 51% to 60%)). Approximately 283 million people lived in households where ⩾3 people slept in a single room (median percentage of at-risk households 15% (95% CI, 13% to 19%)). An estimated 890 million Africans lack on-site water (71% (95% CI, 62% to 80%)), while 700 million people lacked in-home soap/washing facilities (56% (95% CI, 42% to 73%)). The median percentage of people without a refrigerator in the home was 79% (95% CI, 67% to 88%), while 45% (95% CI, 39% to 52%) shared toilet facilities with other households. Individuals in low-resource settings have substantial obstacles to implementing NPIs for mitigating SARS-CoV-2 transmission. These populations urgently need to be prioritised for coronavirus disease 2019 vaccination to prevent disease and to contain the global pandemic.